PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26593430-0	2015	Farrerol can attenuate the aortic lesion in spontaneously hypertensive rats via the upregulation of eNOS and reduction of NAD(P)H oxidase activity.	farrerol	0-8	nitric oxide synthase 3	Rattus norvegicus	100-104	
26593430-5	2015	Moreover, the levels of O2(-) along with NAD(P)H oxidase activity were reduced (P<0.05), while the activity of endothelial nitric oxide synthase (eNOS) was elevated (P<0.05) in aortic homogenates after the intervention of farrerol.	farrerol	228-236	nitric oxide synthase 3	Rattus norvegicus	114-147	
26593430-5	2015	Moreover, the levels of O2(-) along with NAD(P)H oxidase activity were reduced (P<0.05), while the activity of endothelial nitric oxide synthase (eNOS) was elevated (P<0.05) in aortic homogenates after the intervention of farrerol.	farrerol	228-236	nitric oxide synthase 3	Rattus norvegicus	149-153	
26593430-6	2015	Furthermore, farrerol upregulated the expression of eNOS in both of mRNA and protein levels, accompanied by the downregulated mRNA and protein expression of p22(phox) (P<0.05), an essential subunit for NADPH oxidase activity.	farrerol	13-21	nitric oxide synthase 3	Rattus norvegicus	52-56	
26593430-7	2015	Our findings indicated that farrerol has a significant protective effect against the aortic lesion in SHR, which may be related to the enhanced eNOS activity and reduced NAD(P)H oxidase activity.	farrerol	28-36	nitric oxide synthase 3	Rattus norvegicus	144-148